Dyadic International
Dyadic International is a global biotechnology company headquartered in Jupiter, Florida, with its research and development center in the Netherlands. The company uses its patented and proprietary technologies to conduct research, development, and commercial activities for the discovery, development, manufacture, and sale of enzymes and other proteins for diverse industries including bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes.
Top Stages
2 past transactions
VLPbio
Seed Round in 2018
VLPbio is a biotechnology company specializing in the research and development of chimeric virus-like particles (VLPs) to create innovative vaccines for both human and animal health. The company focuses on developing prophylactic and therapeutic vaccines aimed at addressing unmet medical needs in the fields of oncology and infectious diseases. Utilizing a patented immunotherapeutic platform, VLPbio employs proprietary antigen-display nanoplatforms based on VLP technology. This approach enables healthcare professionals to effectively treat a range of conditions, contributing to advancements in both human and veterinary medicine.
BDi Biotechnology Group
Seed Round in 2018
BDi Biotechnology Group Specialized in contract research management services.
A biotechnology customer-centric company with strong background, providing solutions in health and food sectors. It provide services helping their clients with a high level of flexibility, cost oriented, open communication, reliability and confidentiality. They also provide products thanks to their own antigen display technology with a strong potential to boost and direct specific immune responses, humoral or cellular depending on the construct.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.